Fact CheckerSign in

NCT07295249Completed

Asthma Health Literacy Scale for Children (AHLSC) (Aged 8-12)

Asthma Health Literacy Scale for Children (AHLSC) (Aged 8-12): A Scale Development Study

Source: ClinicalTrials.gov · Last updated 29 Dec 2025

Brief summary (registry, in English)

Asthma Health Literacy Scale for Children (AHLCS) (Ages 8-12): A Scale Development Study Objective: This study will be conducted using a methodological design to develop and examine the psychometric properties of the Asthma Health Literacy Scale for Children (AHLCS) for children aged 8-12 years.

Status (registry)
Completed
Study type
Observational
Enrollment
196 (actual)
First submitted
7 Dec 2025
Start date
15 Feb 2025
Primary completion date
16 May 2025
Lead sponsor
University of Yalova
Diseases
Asthma
NCT number
NCT07295249

What you commit to

  • Study type: Observational
  • Participants enrolled: 196
  • From 15 Feb 2025 to the primary completion date, 16 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Children who filled out the data forms incompletely.

Who the study is looking for

  • Having been diagnosed with asthma for at least one year.
  • Not having any mental and/or physical health problems that would prevent communication.
  • Agreeing to participate in the research.
  • Parental consent obtained.
  • Being between the ages of 8-12.

Age in the registry: 8 years to 12 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Emel Avçin
Coordinator of this site? Confirm its status
AdıyamanTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.